$PG

P&G (PG) Q1 2027 Earnings Call Transcript

P&G (PG) reported Q1 2027 earnings with organic sales growth across all 10 product categories and 6 regions. North America and Europe grew 3% and 4% respectively, while Greater China saw 8% growth. Core EPS was $2, down 1 point YoY. The company maintained guidance for fiscal 2027 and highlighted successful product launches like Pantene's Abundant and Strong, Pampers Amoira, and Fairy Dish.

Original reporting
Published Oct 22, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
P&G (PG) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$PGNeutralMed
01

Why it matters

The earnings release offers fresh data on revenue growth and margin trends, informing short‑term price expectations.

02

Market read

Large‑cap consumer staple earnings with mixed signals on growth and profitability, relevant for sector positioning.

03

What to watch

Strong cash flow productivity and $3.9 bn share‑return program may offset short‑term margin concerns.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

P&G provided its Q1 2027 earnings call transcript, outlining organic sales growth, category performance, and financial metrics.

Company-level read

Ticker impact

$PGNeutralHigh confidence
Context

P&G disclosed Q1 2027 earnings with core EPS $2, margin compression and maintained fiscal guidance.

Expected impact

likely modest downside as investors digest lower margins despite revenue growth

Evidence & confidence

Revenue grew across categories and regions, but core gross margin fell 150 bps and operating margin fell 80 bps, offsetting the EPS beat.

Market effects

Consumer staples peers may see similar margin pressure as input costs rise.

North America and Greater China growth may boost regional consumer‑goods sentiment.

Large‑cap consumer staple earnings influence broader market direction.

Counterpoint

Despite margin compression, continued share gains and cash returns could support upside.

Key entities

  • Procter & Gamble

    Consumer‑goods conglomerate reporting Q1 2027 results.

Related articles

$PGHighAI 9/10

Procter & Gamble Stocks Gain 5.62% on Volume-Led Quarter

Procter & Gamble (PG) reported a 4% sales increase to $23.3B in Q1, driven by volume growth. Shares rose 5.62% to $165.65. Earnings grew 1% to $1.97 per share, but higher costs impacted margins. Operating cash flow was $5.8B, supporting dividends and buybacks. The stock trades near its GF Value estimate.

$PGMedAI 8/10

The Procter & Gamble Company Q1 2027 Earnings Call Summary

Procter & Gamble reported Q1 2027 organic sales growth of 4.0%, driven by volume increases and strategic interventions. Market share improved in the U.S. and China, with the latter benefiting from competitive dynamics. The company maintained fiscal 2027 guidance for 1%-3% organic sales growth, despite a $1.4 billion after-tax headwind from raw materials and energy. Management expects sequential acceleration in sales growth and plans to offset costs through productivity gains and pricing actions.

$PGHighAI 8/10

Procter & Gamble earnings analysis: questions answered and next catalysts

Procter & Gamble (PG) reported fiscal Q1 2027 earnings beating estimates with EPS of $2.00 and revenue of $23.28B. Organic sales grew 4.0%, and all categories and regions showed growth. However, margins fell due to rising commodity costs, and the company raised its cost-headwind estimate to $1.9B. The stock is trading at $166.58, near its 52-week high, with a market cap of $387B.

$PGHighAI 8/10

Procter & Gamble (PG) Reports Strong Q1 Results with Accelerated

Procter & Gamble (PG) reported Q1 results with core EPS of $2.00 and revenue of $23.28 billion, both exceeding estimates. Organic sales grew 4%, driven by volume and pricing. All product categories and regions saw growth, but margins declined due to rising costs. PG raised its FY27 commodity cost estimate to $1.4 billion. Management expects continued growth but warns of volatility.